These findings parallel broader atherosclerosis research, where sustained elevation of inflammatory biomarkers such as IL-6 is well established as a risk factor for cardiovascular recurrence and diminished procedural durability in large-scale analyses [30]. Here, IL6 is linked to atherosclerosis.